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The  present  work  was  performed  to  initiate  a  comprehensive  study  of  the 
relationship  between  structure  and  function  of  the  human  C4  molecule. 
Activated  C4 fulfills several different functions,  including (a) binding through a 
labile-binding site to molecules and particles such as immunoglobulins,  immune 
complexes,  viruses,  bacteria,  and  animal  cells  (1),  (b)  interaction  through  a 
specific and stable-binding site with an immune  adherence receptor present on a 
variety of cells  (2-4),  (c)  interaction  with  activated  C2  to  form  the  enzyme  C3 
convertase  (5),  and  (d)  interaction  with  activated  C2  and  C3  to  form  C5 
convertase  (6). 
Isolation and description of C4 was first accomplished in 1963  (1). The protein was found 
to  be  a  /31-globulin with  a  sedimentation  coefficient of  10S.  Its  cytotoxic activity was 
abolished by  treatment  with  hydrazine  or  potassium  bromide  which  also  changed  its 
electrophoretic mobility. During the cytolytic reaction a small percentage of C4 molecules 
was shown to be physically bound to the target cell, whereas the majority of C4 molecules 
accumulated in the fluid phase in inactivated form. This reaction is catalyzed by the C1~ 
subunit of C1  (7). Later it was recognized that a low molecular weight activation peptide, 
C4a, was released during the binding reaction and that the major fragment, C4b, was the 
portion of the molecule which was bound to the target cell surface (8-10). The mol wt of 
native C4 was estimated to be 202,000 daltons and that of C4a to be approximately 10,000 
daltons (9,  10). 
The  purpose  of  this  paper  is  twofold:  (a)  To  describe  a  modification  of  the 
method  of isolation of human  C4,  and  (b)  to  propose  a  molecular model of C4 
which  is based  on  an  analysis of' its polypeptide  chain  structure. 
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Materials and Methods 
Materials.  The  following  materials  were  purchased:  phenylmethylsulfonylfluoride (PMSF) 1 
(Calbiochem, San Diego,  Calif.), TEAE-cellulose (Gallard-Schlesinger Chemical Mfg.  Corp.,  Long 
Island, N.  Y.),  Biogel A-0.5 M  (Bio-Rad Laboratories, Richmond, Calif.), Pevikon C-860  (Mercer 
Consolidated Corp., Yonkers, N. Y.), QAE-Sephadex (Pharmacia Fine Chemicals, Inc., Piscataway, 
N. J.), reference proteins for SDS gel electrophoresis (Worthington Biochemical Corp., Freehold, N. 
J.), SDS {Sigma Chemical Co.,  St. Louis, Mo.), and dithiothreitol {DTT)  (Bio-Rad). 
Serum.  Serum was obtained from freshly drawn O ÷ human blood, purchased from the San Diego 
Blood Bank, San Diego, Calif. Usually 2 U of blood were used for one preparation. 
Preparation of Pseudoglobulin.  To prevent activation of C1,  the sera of 2 U of blood were not 
pooled, but processed separately. ~Fo each serum unit PMSF was added (dissolved in 5 ml isopropyl 
alcohol) to a final concentration of 0.25 mg PMSF/ml serum. Pseudo- and euglobulin fractions were 
partitioned by  dialysis at  4°C  against  3  x  10  liters  of 0.0125  M  Tris-HC1  buffer,  pH  7.0.  The 
precipitated euglobulins were removed by centrifugation at 16,000 g for 30 min at 4°C. After PMSF 
was again added to the supernatant pseudoglobulin, this fraction was used as the starting material for 
the isolation of C4. 
TEAE-CeUulose  Chromatography.  The  pseudoglobulin fraction from  1 U  of serum  {approxi- 
mately 200  ml)  was applied to a  5.0 x  80-cm column of TEAE-cellulose equilibrated with 0.02  M 
phosphate buffer, pH 7.3  (buffer A).  Immediately after the first unit had entered the column, the 
second  unit  of pseudoglohulin was  applied.  The  column  was  washed with  6  liters  of buffer A 
containing enough sodium chloride to adjust the conductivity to 9 mmho/cm (buffer B). C4 was then 
eluted by a salt concentration gradient. The mixing chamber, a 3,000 ml florence flask, containing 
3,000 ml of buffer B, was connected by a siphon to a 3,000 ml Erlenmeyer flask containing 2,500 ml of 
0.45  M  sodium chloride in buffer B. 20-ml fractions were collected at a  flow rate of 200  ml/h. C4 
containing fractions were pooled, filtered through a Millipore filter with a pore size of 0.45 um and 
concentrated to 5.0 ml. The concentration of all protein solutions was effected by utilizing an Amicon 
concentration device (Amicon Corp., Lexington, Mass.) with a UM 10 filter. 
Gel Filtration.  The concentrated TEAE-cellulose pool was passed over a 5.0 x 100-cm column of 
Biogel  A-0.5  M  equilibrated with 0.1  M  phosphate buffer,  pH  7.3,  at  4°C.  5-ml fractions were 
collected at a flow rate of 50 ml/h. C4 containing fractions were pooled, passed through a Millipore 
filter, concentrated to 4 ml, and dialyzed against 2 x  1 liters barbital buffer, pH 8.6,  ionic strength 
0.05. 
Preparative Electrophoresis.  The concentrated C4 pool from the Biogel column was applied to a 
1 x 20 x 50-cm block of Pevikon C-860 equilibrated with pH 8.6 barbital buffer. Electrophoresis was 
performed at 4°C for 24 h at 3.5 V/cm. C4 containing eluates of block segments were pooled, filtered 
through Millipore filters, and concentrated to 10 ml. The concentrate was dialyzed against 3 x  1 liters 
of QAE-Sephadex chromatography starting buffer. 
QAE-Sephadex  Chromatography.  The  Pevikon  block  C4  pool  was  applied  to  a  2.3  x  65-cm 
column of QAE-Sephadex A-50  equilibrated with 0.004  M  phosphate buffer, pH  7.3,  containing 
sodium chloride to give a conductivity of 22 mmho/cm. After adsorption of the applied material, the 
column was washed with 400  ml of starting buffer and  C4  was eluted with a  salt  concentration 
gradient. The mixing chamber, a 1,000 ml florence flask, containing 1,000 ml of QAE starting buffer, 
was connected by a siphon to a 1,000 ml Erlenmeyer flask containing 850 ml of starting buffer, the 
conductivity of which had been adjusted to 40 mmho/cm. 6-ml fractions were collected at a flow rate 
of 25 ml/h. 
Detection  of  C4  Hemolytic  Activity.  This  was  done  by  adding  5-  to  50-ul  aliquots  of C4 
containing fractions to a system consisting of 0.5 ml gelatin containing veronal buffer, 20 ~g isolated 
C3, 0.1 ml hydrazine-treated human serum diluted 1/5, and 0.4  ml erythrocytes (E)  sensitized with 
antibody (A) at a concentration of 5 x  108/ml. After incubation for an appropriate time which did not 
allow 100% lysis to occur in any reaction mixture, the reaction was stopped by addition of 2.0 ml ice- 
~Abbreviationa  used  in  this  paper:  A,  antibody;  DTT,  dithiothreitol;  F,  Forssman  antigen; 
PMSF, phenylmethylsulfonylfluoride; Sbl, labile-binding site; Sbs, stable-binding site. 1326  FOURTH COMPONENT OF HUMAN COMPLEMENT 
cold saline and centrifugation.  The degree of lysis was determined speetrophotometrically at 541 nm. 
Treatment  of C4 with C1 Esterase.  Purified C4 was digested with purified C1 esterase according 
to the method described (7). 
Analytical  Electrophoresis.  Immunoelectrophoresis was  performed  according  to  Scheidegger 
(11). Disc eleetrophoresis  was performed  using the method of Davis (12) employing 6% running gels 
and Tris-HCl-glycine buffer,  pH 8.7. 
SDS-Polyacrylamide  Gel  Electrophoresis.  Molecular  weights  of  C4  and  its  subunits  were 
determined in 7% polyacrylamide gels containing 0.1% SDS in phosphate buffer, pH 7.25, according 
to the method of Weber and Osborn (13). 1 vol of protein solution  was mixed with 1 vol of phosphate 
buffer containing 8.5 M urea,  2% SDS, and 0.014 M DTT. The mixture was held at 37°C for 45 min, 
when an equal volume of 50% glycerol in water was added which was saturated with bromphenol blue. 
Eleetrophoresis  was performed  using  25-M aliquots in 6 x 100-mm gel columns  for 3 h at 8 milliam- 
peres/gel  in  a  Hoefer gel electrophoresis  apparatus  (Hoefer  Scientific Instruments,  San Francisco, 
Calif.).  The  electrode vessels  were  filled with  0.1  M  phosphate  buffer,  pH  7.25, containing 0.1% 
SDS.  The gels were  stained  twice,  first  with 0.2% amido Schwartz  dissolved  in  methanol-water- 
acetic acid (4.5:4.5:1), for 30 min, then destained by diffusion in the same solvent and stained the sec- 
ond time for 18 h with 0.025% Coomassie Blue in 10% TCA. Destaining was carried  out in 10% TCA 
and gels were stored for evaluation in 7% acetic acid. Proteins used as tool wt markers  were reduced 
a2-macroglobulin  (185,000),  reduced  B-galactosidase  (135,000),  reduced  Cls  inhibitor  (105,000) 
(supplied by Dr.  Peter Harpel,  New York  Hospital--Cornell Medical Center,  New  York), reduced 
phosphorylase  A (92,500), reduced  fibrinogen  (70,000, 60,000, and  50,000), reduced  glucose-6-phos- 
phate  dehydrogenase  (36,000), reduced  Clg  light  chain  (31,600), and  reduced  chymotrypsinogen 
(25,500). When  radiolabeled  C4 was used,  gels were sliced into 2-mm  wide  discs  and analyzed for 
radioactivity in a Packard auto-gamma scintillation spectrometer (Packard  Instrument Co., Downers 
Grove, Ill.). 
Radiolabeling  of  Purified  C4.  Purified  C4  was  radiolabeled  with  125I by  the  method  of 
MeConahey and Dixon (14). 250 #g C4 protein  in 1 ml saline was treated with 5 ttg chloramine T and 
200 pCi  ~25I for 10 min at 4°C after which time 5 #g of sodium metabisulfite was added.  Uptake of 
iodine was approximately 20% and specific radioactivity 0.16 ttCi/#g. Excess iodine was removed by 
dialysis  against 3 × 10 liters of 0.85% NaC1 followed by dialysis against 1 x 1 liters of 0.1 M phosphate 
buffer,  pH 7.3. 
Preparation of Forssman (F) Antigen  Containing Erythrocyte  Fragments, Antibody  (A), and  C 
Complexes.  Sheep  erytbrocyte  (E)  membrane  fragments  containing  Forssman  antigen  were 
prepared  as  described  by Rapp and  Borsos (15). FAC1,4 complexes  were prepared by the method 
used  for preparation of EAC1,4 as outlined previously using  [12~I]C4 (8). 
Dissociation  of  C4  from  FAC1,4.  [125I]C4 was  dissociated  from  FAC1,4  by  incubation  with 
SDS-urea or SDS-urea-DTT (see above)  for 45 min at 37°C.  Membrane fragments were separated 
from the released  [1~I]C4 by centrifugation for 10 min at 7,000 g. The C4 containing supernate was 
subjected to SDS-polyacrylamide gel electrophoresis. 
Results 
Isolation of C4.  Starting  material  for the  purification of C4  consisted of the 
pseudoglobulin  fraction  formed  by  dialysis  of serum  against  low ionic strength 
Tris-HC1 buffer at  pH 7.0.  This procedure yields 30%  more C4 than preparation 
of the  pseudoglobulin  fraction at  pH 5.4.  To prevent possible C1  activation,  all 
operations  were  performed  strictly  at  4°C  and  pooling  of  individual  sera  was 
omitted. Further,  to inactivate possibly present active Clg, PMSF  was added to 
the  initial sera and to the pseudoglobulin preparations. 
Upon  application  of  the  pseudoglobulin  fraction  to  TEAE-cellulose,  the 
majority of the proteins eluted from the column with buffer A. C4 could then be 
separated  from  the bulk  of the  other  proteins  still adsorbed  to  the  cellulose by 
gradually  increasing the  salt  concentration.  C4  activity was  found  in  fractions 
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Fro.  1.  Second step of C4 isolation: Chromatography of pseudoglobulin fraction on TEAE- 
cellulose.  The pseudoglobulin fractions from 2  U  of serum  were  applied  to  a  5.0  x  80-cm 
column of TEAE-cellulose equilibrated with 0.015 M  phosphate buffer, pH 7.3.  A  major por- 
tion of the pseudoglobulin was eluted by washing the column with buffer B at a flow rate of 150 
ml/h at  4°C  before  a  salt gradient was applied  at fraction  1.  C4  containing fractions were 
pooled as indicated by the bar. 
An  additional threefold purification of C4  was  achieved by molecular sieve 
chromatography using Biogel A-0.5  M  (Fig. 2).  The elution volume of C4 was 
approximately 1.3 times the void volume. 
The C4 pool was next subjected to preparative electrophoresis at pH 8.6. Fig. 3 
shows a portion of the elution profile of the Pevikon block. C4 was well separated 
from ceruloplasmin and albumin but partially overlapped in distribution with 
that  of  C3.  An  approximately  fourfold  purification  was  achieved  with  this 
isolation step. 
Final separation of C4 from C3 and other contaminants was achieved by ion 
exchange chromatography using QAE-Sephadex. Under the conditions used, C4 
binds tightly to the anion exchanger and is eluted only after the conductivity has 
reached  approximately  30  mmho/cm  as  seen  in  Fig.  4.  This  figure  also 
demonstrates correspondence between the distribution of C4 hemolytic activity 
and that of the protein. A twofold purification was achieved in this last step. The 
entire isolation procedure is summarized in Table I. The degree of purification, 
recovery, and yield are listed in Table II. 
Purity  of  C4.  The  purity  of  the  C4  isolated  by  the  above  method  was 
established using a number of different techniques. Ouchterlony analysis gave a 
single precipitin line with various antisera to whole human serum. A reaction of 
identity was  observed  when isolated C4  was  analyzed with  antiwhole human 
serum and anti-C4. No line was seen with antisera to albumin, IgG, IgA,  IgM, 
transferrin,  ceruloplasmin,  C3,  C5,  and  ~-lipoprotein.  Upon  immunoelectro- 
phoresis a  single precipitin arc  developed with an antiserum to whole human 
serum and this appeared to be identical to the arc produced by antiserum to C4 
(Fig. 5). Polyacrylamide gel electrophoresis showed (Fig. 6) a major component, 
but also a  minor faster and minor slower band. That these bands represent con- 
version  products  of  C4  was  verified  by  subjecting  Cl~-treated  C4  to  poly- 
acrylamide gel electrophoresis.  After this treatment the major species of mole- 
cules disappeared and gave rise to the fast- and slow-migrating protein  zones. 1328  FOURTH COMPONENT OF HUMAN COMPLEMENT 
0.6 












-0.1  ° 
lO0  2'5  5'0  7'5 
Fractiun  Number 
Fro.  2.  Third step of C4 isolation: Molecular sieve chromatography through Biogel A-0.5 M 
of C4 containing pool from second step. The concentrated protein pool from the previous step 
was injected into a 5.0  ×  100-cm column of Biogel A-0.5 M equilibrated in 0.1 M  phosphate 
buffer, pH 7.3. The column was eluted at a flow rate of 50 ml/h at 4°C. C4 containing fractions 
were pooled as indicated by the bar. 
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Fro.  3.  Fourth step of  C4  isolation:  Preparative  electrophoresis  on  Pevikon  block of C4 
containing pool from  third  step.  The concentrated  C4  pool from the Biogel column was 
subjected to electrophoresis at pH 8.6 on a I x 20 × 50-cm block of Pevikon C-860  for 24 h at 60 
milliamperes  and 3.5 V/cm  at 4°C. Origin is indicated  by the arrow and the block was sec- 
tioned into 1.25-cm  segments. Shown is a partial elution profile of a typical block. C4 contain- 
ing fractions were pooled as indicated by the bar. 
Subunit Structure of C4.  Purified C4 was subjected to electrophoresis in 7% 
polyacrylamide  gels  containing  SDS.  Fig.  7  shows  the  results  of  one  such 
experiment.  When  treated with  SDS  and  urea  (gel a),  C4  migrates  as a  major 
band  with  a  mol  wt  209,000  ±  5,000  daltons.  Prior  treatment  of C4  with  C1 
esterase leads to partial aggregation, but no detectable change in the molecular 
weight of the monomer (gel b). Reduction of' C4 in the presence of SDS and urea 
gives rise to three distinct polypeptide chains  (gel c). The calculated mol wt of 
these  chains  are:  a,  93,000  ±  2,000;  ~,  78,000  ±  2,000;  and  ~,  33,000  ±  300 
daltons.  If C4  is treated with  C1  esterase before reduction,  only the a-chain is 
affected (gel d). The mol wt of C1~ cleaved a-chain (a'-chain)  is 87,000 daltons. 
Therefore, the peptide removed from the a-chain was assigned a  mol wt of 6,000 
daltons.  C4a  was  not detected  in  these  experiments.  Alkylation of reduced  C4 ROBERT  D. SCHREIBER  AND HANS J. MiJLLER-EBERHARD  1329 
-40 
.10  ,~ 
.08  -  "  .~ 
30 
'~  .06  a-'o"a"  i 
.04  .  _a-- 
,02  ~  .1]  20 " 
s'o  loo  lio 
Fraction Humber 
Fro. 4.  Fifth step of C4 isolation: Chromatography of C4 containing pool from fourth step on 
QAE-Sephadex. The concentrated C4 containing pool from the previous step, which had been 
dialyzed against QAE starting buffer, was applied to a  2.3 x  65-cm column of QAE-Sephadex 
A-50 equilibrated in starting buffer. The column was washed with the same buffer at a flow 
rate of 20 ml/h at 4°C  to remove those proteins which were not bound by the ion exchanger 
under  the  given  conditions  before  a  salt  gradient  was  started  at  fraction  1.  Note  the 
correspondence of C4 activity and protein distribution in the major peak. 
TABLE  I 
Modified Procedure for Isolation of C4 
1.  Preparation ofpseudoglobulin: 
2.  Ion exchange chromatography: 
3.  Gel filtration: 
4.  Preparative electrophoresis: 
5.  Ion exchange chromatography: 
Dialysis of fresh serum against 0.0125 M  Tris-HC1 
buffer, pH 7.0, supernate 
TEAE-cellulose, salt gradient 
Biogel A-0.5 M, 0.1 M  P04 buffer, pH 7.3 
Pevikon block; barbital buffer, pH 8.6, T/2  =  0.05 
QAE-Sephadex, salt gradient 
TABLE  II 
Purification and Yield for Human C4 Isolation 
Effective molecules/ 
Material  Protein  Effective molecules  protein 
mg  mg 
Serum  36,400  2.4 x  1015  6.6  x  101° 
Pseudoglobulin  33,800  1.0 x  10 is  3.0  ×  10 ~° 
TEAE-cellulose pool  238.7  ND  ND 
Biogel pool  55.8  8.5 ×  1013  1.52 ±  1012 
Pevikon block pool  23.8  8.0 ×  101~  3.4  ×  1012 
QAE-Sephadex pool  8.16  7.5 x  10 la  9.2  ×  1012 
C4 activity yield: 3.2%; purification: 139  ×. 
before  SDS  electrophoresis  had  no effect on the  resultant  patterns.  Staining  with 
periodic  acid-Schiff  (PAS)  indicated  the  presence  of carbohydrate  in each  of the 
three  chains. 
To  verify  the  three  chain  structure  of  C4,  two  experiments  were  performed. 1330  FOURTH COMPONENT OF HUMAN COMPLEMENT 
Fro.  5.  Immunoelectrophoretic representation  of  isolated  C4.  Immunoelectrophoresis of 
isolated C4 was performed in 1% ion agar at pH 8.6 at 4°C for 2 h. Anode is at the right. 
FIG. 6.  Disc gel electrophoresis of C4 and Cl~-treated C4. 25 #g of isolated C4 or isolated C4 
treated with  1%  (wt/wt)  C1~  were subjected to  electrophoresis in  6%  polyacrylamide gels. 
Anode is at the bottom. 
First, gel c was scanned at 550 nm and the adsorbance of the stained bands was 
calculated  and  compared  with  the  molecular  weight  of  the  corresponding 
polypeptide  chain.  As  shown  in  Table  III,  the  ratios  of the  amount  of stain 
correspond  well  to  the  molecular  weight  ratios  for the  respective polypeptide 
chains. 
Second, the chain structure of C4b was examined after it had been specifically 
bound to immune complexes through the action of C1 and then dissociated from 
them. Membrane fragments of sheep erythrocytes containing F were treated with 
A to F, C1, and  ['2~I]C4. The FAC1,4 complexes were washed and dissociated in 
SDS and urea either with or without DTT. The supernate was then subjected to 
SDS  gel  electrophoresis  and  the  gels  were  analyzed  for  the  distribution  of 
radioactivity. The pattern of' radioactivity of the  reduced eluted material was 
very similar to that obtained with reduced C4b.  Specifically, in addition to a'- 
and  B-chains,  the  lower molecular weight  ~,-chain  was  clearly present (Fig.  8). ROBERT D. SCHREIBER AND HANS J. MI)LLER-EBERHARD  1331 
FIG.  7.  Demonstration  of  three  C4  polypeptide  chains  and  of the  effect  of  Clg  on  C4 
structure. Reduced and unreduced samples of C4 were subjected to electrophoresis through 7% 
polyacrylamide gels containing SDS. Gel (a)  contains unreduced C4 which migrates mostly as 
a  single  component  of  mol  wt  209,000  daltons,  Heavier  material  probably  represents 
polymerized C4i. Gel (b)  shows the effect of CI~ treatment on unreduced C4. The position of 
the major component  does not show any major changes,  although  more heavy material has 
been produced. The faster moving zone is Clg and the diffuse band at the bottom of the gel is a 
contaminant  in  the  Clg preparation.  Gel  (c)  shows that  reduction  in the  presence of SDS 
dissociates  C4  into  three  distinct  polypeptide  chains  of mol  wt  93,000,  78,000  and  33,000 
daltons. Gel (d) represents Clg-treated C4 which was then reduced. Only the a-chain shows a 
reduction of molecular weight. The band intermediate between/~ and y is CI~ heavy chain. CI~ 
light chain is partially covered by the y-chain. 
TABLE III 
Comparison  of Molecular  Weight and Staining Ratios of Component 
Chains  of C4 after SDS-Polyacrylamide Gel Electrophoresis 
Subunits  Molecular weight  Stain ratio 
ratio 
a/t~  93,000/78,000  = 1.19  1.15 
~/y  93,000/33,000  = 2.8  2.4 
~/y  78,000/33,000  = 2.4  2.1 
Discussion 
The  data  presented  in  this  paper  indicate  that  C4  is  composed  of'  three 
polypeptide  chains  which  differ in  molecular  weight  and  are linked  by  disulfide 
bonds  and  noncovalent  forces.  The  mol wt of the a-,  B-, and  ~-chains  are 93,000, 
78,000  and  33,000  daltons,  respectively.  The  sum  of  the  mol  wt  of  the  chains, 1332  FOURTH COMPONENT  OF HUMAN COMPLEMENT 
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FIG.  8.  Verification of  multiple  polypeptide  chains  in  C4b  specifically  bound to  immune 
complexes.  [125I]C4 which had been specifically bound to immune complexes was eluted by 
treatment with SDS-urea-DTT and subjected to SDS polyacrylamide gel electrophoresis. The 
gels were sliced and analyzed for radioactivity. Counts per minute are plotted against segment 
number. The origin is at the left, the anode is to the right. The eluted, reduced C4b (top panel) 
gives  a  pattern  very  similar  to  Cl~-treated  C4  which  was  then  reduced  (middle  panel). 
Reduced,  native C4 is shown in the bottom panel. 
204,000 daltons  is  in  close agreement with the  mol wt of the undissociated C4 
molecule, which is 209,000 daltons. These values also indicate that each chain 
occurs only once in the intact molecule. This concept is further supported by the 
estimated molar ratios of' the subunits. Since a composition of three subunits is 
rare for protein molecules, the possibility of' contamination had to be excluded. 
The following facts lend support to the three chain  model:  (a)  The method of 
isolation employed in  this study produced C4 which was pure by physical and 
immunochemical criteria. (b)  The three subunit SDS gel pattern of reduced C4 
has  been established for eight different C4 preparations.  (c) The three subunit 
pattern was observed for fully active as well as Clg-treated C4. (d) C4b which was 
specifically bound to immune complexes and  was then dissociated showed the 
same type of pattern as control C4b. 
Treatment of C4 with Clg was shown previously to result in cleavage of C4 and 
dissociation of a  low molecular weight fragment, C4a (9,  10). After the action of 
C1~  only  the  a-chain  showed  a  reduced  molecular  weight.  This  observation 
indicates  that  C4a  is  derived  from  the  a-chain  of C4,  and  suggests  that  the 
a-chain  contributes to the  generation of the  labile-binding site  (Sbl)  through 
which activated C4 participates in C-dependent cytolysis. The mol wt difference 
between the a- and d-chain is 5,000-7,000 daltons. It is not clear, therefore, why 
isolated C4a  was found in earlier studies in this laboratory to have a  tool wt of 
11,000-15,000 daltons (9). The possibility is considered that C4a was isolated as a ROBERT  D. SCHREIBER AND HANS J. MULLER-EBERHARD  1333 
dimer. However, Patrick and Lepow reported a mol wt of 8,600 daltons (10). Since 
C4-dependent immune adherence has  previously been  reported  (2-4),  the cell 
bound C4b fragment is envisioned to be endowed with a stable-binding site (Sbs) 
which  reacts  with  specific  cellular  receptors.  A  schematic  drawing  of  the 
proposed model of C4 is shown in Fig. 9. 
It  is  of interest to compare the proposed structure of C4 with the proposed 
structure of C3  (16).  C3 contains two polypeptide chains (a  and ~3)  joined by 
disulfide bonds  and  noncovalent forces,  the  mol  wt  of which are  120,000 and 
75,000 daltons, respectively (17). Activation of C3 is affected by the action of C3 
convertase (C4,2)  (5), a trypsin-like enzyme, which cleaves a small peptide (C3a) 
(18, 19) from the N-terminus of the a-chain (20). Once activated, the C3b portion 
of the molecule is capable of binding to cells through the newly exposed Sbl (21). 
Bound C3b also contains a second Sbs which reacts with the immune adherence 
receptor of a variety of cells (22). 
In several  respects  C4  is  similar to  C3.  Both molecules contain /~-chains of 
approximately the same size and a-chains that are heavier than the B-chains. In 
both molecules the Sbl is exposed by action of the respective activating enzyme 
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FIG. 9.  Schematic presentation of proposed tertiary structure of C4. 
on the a-chain with concomitant fokmation of a small peptide. Both b fragments, 
in their bound form, are endowed with immune adherence reactivity. In addition, 
Sobel and Bokisch (3) and Ross and Polley (4) have shown that in some instances 
the reaction of bound C3b with specific cellular receptors can be inhibited with 
soluble C4b and vice versa, suggesting a structural similarity of the Sbs of both 
molecules. These observations are compatible with the view that both molecules 
evolved from a  common ancestral protein. However, the structural similarities 
between C3 and C4 diverge with the finding of the 7-chain of C4. It is conceivable 
that this subunit is the structural equivalent to a specific C4 function, namely to 
serve as acceptor of activated C2 in the formation of C3 convertase. More work is 
needed to examine this possibility. 
Summary 
The fourth component of human complement (C4) was shown to be composed of 
three  distinct  polypeptide chains  linked  by  disulfide bonds  and  noncovalent 
forces. The sum of the molecular weights of the chains equalled that of the intact 1334  FOURTH COMPONENT  OF HUMAN COMPLEMENT 
molecule.  The  mol  wt  of  the  a-,  fl-,  and  ~f-chains  were  respectively,  93,000, 
78,000,  and  33,000  daltons.  Action  of  Clg  on  C4  affected  only  the  a-chain, 
reducing its mol wt to 87,000 daltons. The size of the activation peptide,  C4a, is 
therefore  estimated  to  be  6,000  and  that  of" the  major  fragment  C4b,  198,000 
daltons.  Periodic  acid-Schiff-stained  SDS  polyacrylamide gels  of reduced  C4 
revealed  carbohydrate to be associated with all  three chains.  A  modification of 
the original method of isolation of C4 is presented. 
Received for publication 11 July 1974. 
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